Oncolytic Virus Therapy Market
完整報告名稱與涵蓋範圍
Oncolytic Virus Therapy Market Size, Share & Trends Analysis Report By Product (Herpes Simplex Virus (HSV), Adenoviruses, Vaccinia Virus, Vesicular Stomatitis Virus, Newcastle Disease Virus), By Application, By Region, And By Segment Forecasts, 2025-2034
報告摘要
Industry analysis indicates the Oncolytic Virus Therapy Market globally will accelerate at a 24.5% CAGR during 2025–2034.
The Oncolytic Virus Therapy sector involves burden of cancer mounting rapidly with an mounting incidence rate. This domain has witnessed notable transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is fueled by mounting healthcare spending, technological evolution, and the mounting focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region set to deliver the strongest growth trajectory through the forecast period, fueled by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Oncolytic Virus Therapy Market Snapshot
Chapter 4. Global Oncolytic Virus Therapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Penetration & Growth Prospect Mapping
4.6. Clinical Trial/Pipeline Analysis
4.7. Industry Analysis – Porter's Five Forces Analysis
4.8. Competitive Landscape & Market Share Analysis
Chapter 5. Market Segmentation 1: Product Estimates & Trend Analysis
5.1. Product Type & Market Share, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Product:
5.2.1. HSV-based Oncolytic Viruses
5.2.2. Adenoviruses-based Oncolytic Viruses
5.2.3. Vaccinia Virus-based Oncolytic Viruses
5.2.4. Vesicular Stomatitis Virus-based Oncolytic Viruses
5.2.5. Newcastle Disease Virus-based Oncolytic Viruses
Chapter 6. Oncolytic Virus Therapy Market Segmentation 2: Application Estimates & Trend Analysis
6.1. Application Analysis & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following Application:
6.2.1. Melanoma
6.2.2. Prostate Cancer
6.2.3. Breast Cancer
6.2.4. Ovarian Cancer
6.2.5. Others
Chapter 7. Oncolytic Virus Therapy Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Oncolytic Virus Therapy Market revenue (US$ Million) estimates and forecasts by product, 2021-2034
7.1.2. North America Oncolytic Virus Therapy Market revenue (US$ Million) estimates and forecasts by end-user, 2021-2034
7.1.3. North America Oncolytic Virus Therapy Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Oncolytic Virus Therapy Market revenue (US$ Million) by product, 2021-2034
7.2.2. Europe Oncolytic Virus Therapy Market revenue (US$ Million) by end-user, 2021-2034
7.2.3. Europe Oncolytic Virus Therapy Market revenue (US$ Million) by country, 2021-2034
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Oncolytic Virus Therapy Market revenue (US$ Million) by product, 2021-2034
7.3.2. Asia Pacific Oncolytic Virus Therapy Market revenue (US$ Million) by end-user, 2021-2034
7.3.3. Asia Pacific Oncolytic Virus Therapy Market revenue (US$ Million) by country, 2021-2034
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Rest of World
7.4.1. Rest of World Oncolytic Virus Therapy Market revenue (US$ Million) by product, 2021-2034
7.4.2. Rest of World Oncolytic Virus Therapy Market revenue (US$ Million) by end-user, 2021-2034
7.4.3. Rest of World Oncolytic Virus Therapy Market revenue (US$ Million) by country, 2021-2034
7.4.3.1. Middle East
7.4.3.2. Africa
7.4.3.3. Latin America
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Provectus Biopharmaceuticals, Inc.
8.2.2. Takara Bio Inc.
8.2.3. SillaJen, Inc.
8.2.4. Oncorus, Inc.
8.2.5. Amgen
8.2.6. OncoMyx Therapeutics, Inc.
8.2.7. Replimune Inc.
8.2.8. Oncolytics Biotech
8.2.9. Vyriad, Inc.
8.2.10. Viralytics
8.2.11. Transgene SA
8.2.12. Oncolys BioPharma
8.2.13. Unleash Immuno Oncolytics, Inc.
8.2.14. Targovax
8.2.15. PsiOxus Therapeutics
8.2.16. Sorrento Therapeutics
8.2.17. Lokon Pharma AB
8.2.18. Genelux Corporation
8.2.19. TILT Biotherapeutics
8.2.20. Cold Genesys
8.2.21. Western Oncolytics
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們